| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aeterna Zentaris Inc (TO: AEZS)
AEZS Technical Analysis
5
| As on 11th Oct 2024 AEZS STOCK Price closed @ 5.10 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.13 & Strong Buy for SHORT-TERM with Stoploss of 3.84 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AEZSSTOCK Price
| Open | 5.10 | Change | Price | % |
| High | 5.10 | 1 Day | -0.05 | -0.97 |
| Low | 5.10 | 1 Week | -0.08 | -1.54 |
| Close | 5.10 | 1 Month | 0.26 | 5.37 |
| Volume | 286 | 1 Year | 0.80 | 18.60 |
| 52 Week High 13.90 | 52 Week Low 1.91 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| ENB | 60.79 | 1.40% |
| CNQ | 48.30 | 2.31% |
| MFC | 45.33 | -1.56% |
| UEX | 0.50 | 16.28% |
| SU | 57.21 | 0.02% |
| CVE | 22.64 | 0.98% |
| SJR-B | 40.48 | 0.02% |
| AC | 23.97 | -2.16% |
| BCE | 37.27 | -1.25% |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| AEZS Daily Charts |
AEZS Intraday Charts |
Whats New @ Bazaartrend |
AEZS Free Analysis |
|
|
AEZS Important Levels Intraday
| RESISTANCE | 5.10 |
| RESISTANCE | 5.10 |
| RESISTANCE | 5.10 |
| RESISTANCE | 5.10 |
| RESISTANCE | 5.10 |
| RESISTANCE | 5.10 |
| RESISTANCE | 5.10 |
| RESISTANCE | 5.10 |
AEZS Forecast November 2024
| 4th UP Forecast | 6.55 |
| 3rd UP Forecast | 6.08 |
| 2nd UP Forecast | 5.8 |
| 1st UP Forecast | 5.51 |
| 1st DOWN Forecast | 4.69 |
| 2nd DOWN Forecast | 4.4 |
| 3rd DOWN Forecast | 4.12 |
| 4th DOWN Forecast | 3.65 |
AEZS Weekly Forecast
| 4th UP Forecast | 6.22 |
| 3rd UP Forecast | 5.86 |
| 2nd UP Forecast | 5.64 |
| 1st UP Forecast | 5.42 |
| 1st DOWN Forecast | 4.78 |
| 2nd DOWN Forecast | 4.56 |
| 3rd DOWN Forecast | 4.34 |
| 4th DOWN Forecast | 3.98 |
AEZS Forecast2024
| 4th UP Forecast | 30.57 |
| 3rd UP Forecast | 22.4 |
| 2nd UP Forecast | 17.35 |
| 1st UP Forecast | 12.3 |
| 1st DOWN Forecast | -2.1 |
| 2nd DOWN Forecast | -7.15 |
| 3rd DOWN Forecast | -12.2 |
| 4th DOWN Forecast | -20.37 |
Aeterna Zentaris Inc ( TO Canada Symbol : AEZS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AEZS Business Profile
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, a peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen name. Aeterna Zentaris Inc. has a license agreement with Julius-Maximilians-University Wuerzburg for the development of an oral prophylactic bacterial vaccine against COVID-19 disease; development, manufacture, and commercialization of targeted immunosuppressive therapeutic proteins for the treatment of neuromyelitis optica spectrum disorder. It also has a license agreement with Consilient Health Ltd. and Novo Nordisk Biopharm Limited for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina. Address: 315 Sigma Drive, Summerville, SC, United States, 29486
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service